DTC
JANX icon

Deep Track Capital’s Janux Therapeutics JANX Stock Holding History

Deep Track Capital’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.5M Buy
1,187,290
+1,097,701
+1,225% +$15.1M 0.27% 56
2025
Q4 		$1.24M Buy
+89,589
New +$2.11M 0.02% 54

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Deep Track Capital's JANX Position: Q1 2026 in Review

Deep Track Capital increased its Janux Therapeutics (JANX) stake by 1,225% in Q1 2026, buying an estimated $15.1M and bringing the position to 1,187,290 shares worth $16.5M. The position accounts for 0.27% of the portfolio, ranked #56.

Deep Track Capital first reported a position in JANX in Q4 2025 and has held it in 2 quarters since. 190 funds tracked by Wall St. Rank hold JANX as of Q1 2026.

  • Deep Track Capital held 1,187,290 shares of Janux Therapeutics worth $16.5M as of Q1 2026.
  • Deep Track Capital bought 1,097,701 Janux Therapeutics shares in Q1 2026, an estimated $15.1M.
  • Janux Therapeutics made up 0.27% of Deep Track Capital's portfolio in Q1 2026, its #56 holding.
  • Deep Track Capital first reported a position in Janux Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • 190 funds tracked by Wall St. Rank held Janux Therapeutics as of Q1 2026.

Based on Deep Track Capital's 13F filing for Q1 2026, filed 15 May 2026.